Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Age-matched
37%
All-female
12%
Anatomic
37%
Anti-incontinence Procedure
25%
Bladder Outlet Obstruction
100%
Clean Intermittent Catheterization
12%
Conservative Management
12%
Control Subjects
12%
Creatinine
12%
Creatinine Concentration
12%
Creatinine Level
62%
Factor Level
100%
Female Control
12%
Female Patients
37%
Female Volunteers
12%
Inclusion Criteria
12%
Incontinence Surgery
37%
Lower Urinary Tract Symptoms
12%
Male Patients
12%
Matched Control Group
12%
Nerve Growth Factor
50%
Peak Flow
12%
Pelvic Organ Prolapse
62%
Post-void Residual
12%
Qmax
12%
Surgical Correction
12%
Surgical Management
12%
Urinary Biomarkers
25%
Urinary Creatinine
12%
Urinary Nerve Growth Factor
100%
Urodynamics
12%
Valsalva
12%
Medicine and Dentistry
Biological Marker
18%
Bladder Outlet Obstruction
100%
Conservative Treatment
9%
Creatinine
63%
Incontinence
45%
Intermittent Catheterisation
9%
Lower Urinary Tract Symptom
9%
Nerve Growth Factor
100%
Peak Expiratory Flow
9%
Pelvic Organ Prolapse
45%
Prospective Study
9%
Urinary System
100%
Urodynamics
9%
Volunteer
9%
Nursing and Health Professions
Aorta Root Prosthesis
9%
Biological Marker
18%
Bladder Obstruction
100%
Conservative Treatment
9%
Creatinine
54%
Creatinine Urine Level
9%
Female Patient
27%
Incontinence
45%
Intermittent Catheterisation
9%
Lower Urinary Tract Symptom
9%
Nerve Growth Factor
100%
Peak Expiratory Flow
9%
Pelvic Organ Prolapse
45%
Postvoid Residual Urine Volume
9%
Volunteer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
18%
Bladder Obstruction
100%
Creatinine
63%
Incontinence
45%
Lower Urinary Tract Symptom
9%
Nerve Growth Factor
100%
Pelvic Organ Prolapse
45%
Prospective Study
9%
Biochemistry, Genetics and Molecular Biology
Creatinine
54%
Creatinine Urine Level
9%
Nerve Growth Factor
100%
Peak Expiratory Flow
9%
Prospective Study
9%
Urodynamics
9%